Start LEQEMBI®. Change the course of AD1,2
In an 18-month study, LEQEMBI was proven to slow the progression of MCI due to AD and mild AD dementia. Learn more:
MCI=mild cognitive impairment.
To learn about Eisai Patient Support for patients prescribed LEQEMBI, call 1-833-4-LEQEMBI (1-833-453-7362) or click here.